What components should be included in a Durable Medical Equipment (DME) examination for a veteran?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DME Examination Components for Veterans

A Disability Benefits Questionnaire (DBQ) examination for a veteran claiming diabetic macular edema (DME) must include dilated fundus examination with slit-lamp biomicroscopy, optical coherence tomography (OCT) to document retinal thickening, visual acuity testing, and assessment of diabetic retinopathy severity using standardized classification systems. 1

Essential Examination Components

Visual Function Assessment

  • Visual acuity testing with current spectacles and best correction in both eyes 1
  • Intraocular pressure measurement to screen for glaucoma 1
  • Assessment of visual symptoms including blurred vision, distortion, and difficulty with reading or driving 1

Dilated Fundus Examination

  • Dilated binocular stereoscopic ophthalmoscopy is the gold standard for detecting DME, as it allows three-dimensional assessment of retinal thickening 1
  • Slit-lamp biomicroscopy through dilated pupils to evaluate for retinal thickening in the macula 1
  • Systematic documentation of diabetic retinopathy severity using the International Clinical Diabetic Retinopathy Disease Severity Scale 1
  • Gonioscopy when indicated to assess for neovascularization of the iris or angle in cases of severe ischemia 2

Optical Coherence Tomography (OCT)

  • OCT is the most sensitive method for detecting and quantifying DME in high-resource settings 1
  • Retinal map scans locate areas of retinal thickening 1
  • Single line scans detail specific morphologic changes including intraretinal cysts, subretinal fluid, and vitreoretinal traction 1
  • Central subfield thickness measurement determines whether DME is center-involving (within 1 mm of foveal center) or non-center-involving 1

DME Classification Documentation

The examination must classify DME severity 1:

  • No DME: No retinal thickening or hard exudates in the macula
  • Non-center-involving DME: Retinal thickening that does not involve the central 1 mm subfield zone
  • Center-involving DME: Retinal thickening involving the central 1 mm subfield zone

Diabetic Retinopathy Severity Grading

Document concurrent diabetic retinopathy using standardized classification 1:

  • No apparent DR: No abnormalities
  • Mild nonproliferative DR: Microaneurysms only
  • Moderate nonproliferative DR: More than microaneurysms but less than severe NPDR
  • Severe nonproliferative DR: Intraretinal hemorrhages (≥20 in each quadrant), definite venous beading (in 2 quadrants), or intraretinal microvascular abnormalities (in 1 quadrant)
  • Proliferative DR: Neovascularization or vitreous/preretinal hemorrhage

Medical History Components

Diabetes-Specific History

  • Hemoglobin A1c levels and glycemic control status 1
  • Duration of diabetes and type (Type 1 vs Type 2) 1
  • Blood pressure control and history of hypertension 1
  • Serum lipid levels and dyslipidemia management 1
  • Renal status including history of diabetic nephropathy 1

Military Service-Related Exposures

  • Comprehensive occupational and environmental exposure assessment covering chemical, physical, biological, and psychological stress exposures during military service 3
  • Deployment history including number and location of deployments 3
  • Military preventive health measures and any service-connected conditions 3

Systemic Medical History

  • Cardiovascular disease history including myocardial infarction, arrhythmia, coronary artery disease 1
  • Cerebrovascular disease including stroke or transient ischemic attacks 1
  • Current medications including all prescription and over-the-counter preparations 1
  • Pregnancy status in women of childbearing age, as this affects treatment planning 1

Functional Impact Assessment

Vision-Related Quality of Life

  • Assessment of functional abilities including instrumental activities of daily living affected by vision loss 1
  • Impact on reading, driving, and mobility 1
  • Occupational limitations related to visual impairment 1

Documentation for Disability Rating

  • Quantify visual acuity loss in both eyes with best correction 1
  • Document central visual field defects if present from macular edema 1
  • Assess need for vision rehabilitation services 1

Ancillary Testing When Indicated

Fundus Photography

  • Useful for documenting disease activity and tracking progression over time 1, 2
  • Provides objective documentation of vascular changes and hemorrhage patterns 2
  • Feasible alternative in settings where OCT is not available 1

Fluorescein Angiography

  • Not required for DME diagnosis but may guide treatment decisions 1
  • Useful to evaluate macular capillary nonperfusion and microaneurysms in complex cases 1
  • Can differentiate intraretinal microvascular abnormalities from neovascularization 1

Critical Pitfalls to Avoid

  • Never rely on undilated examination alone, as peripheral retinal visualization and stereoscopic macular assessment are inadequate 4
  • Do not use non-mydriatic cameras as the sole screening method for DME evaluation 4
  • Ensure the examiner is skilled in evaluating diabetic retinopathy and DME, as subtle findings may be missed by inexperienced examiners 1
  • Document both eyes separately, as severity may differ significantly between eyes 1
  • Assess for other diabetic complications that may affect disability rating, including peripheral neuropathy and nephropathy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Distinguishing Retinal Arteritis from Phlebitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Retinopathy of Prematurity Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.